Mount Sinai Medical Center in Miami Beach is one of dozens of hospitals across the country selected to participate in the Myocardial Ischemia and Transfusion or MINT trial, a clinical trial sponsored by the National Institutes of Health to test blood transfusion therapies for heart attack patients with anemia. A nonprofit consumer advocacy group, Public Citizen, has asked federal regulators to suspend enrollment in the MINT trial, calling the study unethical because it fails to inform patients of the risk of death or repeat heart attacks. Mount Sinai has not begun enrolling patients for the clinical trial because the hospital has not yet been “activated,” a spokeswoman said Monday.
Mount Sinai Medical Center in Miami Beach is one of dozens of hospitals across the country selected to participate in the Myocardial Ischemia and Transfusion or MINT trial, a clinical trial sponsored by the National Institutes of Health to test blood transfusion therapies for heart attack patients with anemia. A nonprofit consumer advocacy group, Public Citizen, has asked federal regulators to suspend enrollment in the MINT trial, calling the study unethical because it fails to inform patients of the risk of death or repeat heart attacks. Mount Sinai has not begun enrolling patients for the clinical trial because the hospital has not yet been “activated,” a spokeswoman said Monday.
Mount Sinai Medical Center in Miami Beach is one of dozens of hospitals across the country selected to participate in the Myocardial Ischemia and Transfusion or MINT trial, a clinical trial sponsored by the National Institutes of Health to test blood transfusion therapies for heart attack patients with anemia. A nonprofit consumer advocacy group, Public Citizen, has asked federal regulators to suspend enrollment in the MINT trial, calling the study unethical because it fails to inform patients of the risk of death or repeat heart attacks. Mount Sinai has not begun enrolling patients for the clinical trial because the hospital has not yet been “activated,” a spokeswoman said Monday.

Clinical trial fails to disclose risk of death, repeat heart attacks, group says

August 01, 2017 06:31 PM

UPDATED August 01, 2017 06:31 PM

More Videos

  • New high blood pressure guidelines mean 30 million more Americans have hypertension

    Under the new guidelines, the number of adults with high blood pressure will rise to 103 million from 72 million. Hypertension is the leading cause of heart disease and heart-related deaths in the U.S. and worldwide.